Clinical Trials Directory

Trials / Completed

CompletedNCT00801229

Effect of Vyvanse on Driving in Young Adults With ADHD

The Effects of Vyvanse on the Driving Performance of Young Adults With ADHD: A Randomized, Double-Blind, Placebo-Controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 24 Years
Healthy volunteers
Not accepted

Summary

The primary objective of the study is to assess the benefice of Vyvanse on the factors that cause impairments in driving behavior in individuals with ADHD using a driving simulation aimed at examining the factors that cause impairments in driving behavior in individuals with ADHD such as driving speed, collision risk, and visual attention of 60 young drivers (ages 18-24) with ADHD. We hypothesize: 1.) young adults with ADHD treated with Vyvanse will show lower velocity (speed) scores and spend less time driving over the posted speed limit in the driving simulation when compared to subjects taking a placebo; 2.) young adults with ADHD treated with Vyvanse will show a lesser likelihood to collide with a suddenly appearing peripheral object, less difficulty maintaining the vehicle within their lane, and a lesser likelihood of driving through stop signs and solid red traffic lights without slowing down when compared to subjects taking a placebo; and 3.) young adults with ADHD treated with Vyvanse will exhibit more focused visual attention on details in the visual field when compared to subjects taking a placebo while driving. In addition, young adults with ADHD treated with Vyvanse will exhibit less visual tunneling and shorter off-road glances when compared to subjects taking a placebo.

Conditions

Interventions

TypeNameDescription
DRUGVyvanseVyvanse 30, 50, or 70 mg daily
DRUGPlaceboPlacebo 30, 50, 70 mg daily

Timeline

Start date
2008-12-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2008-12-03
Last updated
2014-03-10
Results posted
2011-08-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00801229. Inclusion in this directory is not an endorsement.

Effect of Vyvanse on Driving in Young Adults With ADHD (NCT00801229) · Clinical Trials Directory